Wuhan Wansheng Biotechnology

Wuhan Wansheng Biotechnology Co., Ltd. (trading as WWB; wuhanwanshengbio.com) is a research-compound supplier based in Wuhan, Hubei, China, supplying research peptides, SARMs and raw materials, and notable for having one of the largest published third-party test-report sets of any organisation covered on this wiki.^[1][2]

The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

The organisation operates from Wuhan, Hubei. Neither an incorporation year nor a primary trading domain is documented in sources available to this wiki, and the article does not supply either: an unverified founding year is worse than a blank, because a reader cannot tell one from a verified one.^[1]

What distinguishes the organisation is the size of its published testing record. A body of several hundred third-party reports has been associated with its material, which is a substantially larger set than for any other entity covered here.^[5] That volume is the strongest element of its notability case, and it is also the subject of the longest-running dispute on this talk page — because a large number of reports is not the same as a good testing record, and the article has to be careful not to let the first imply the second.

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe vialled lyophilised material with a batch certificate. Reported certificate content has been variable, and the variance is wider than for most entities covered here — some reports describe purity, water and method, others a single purity line.^[5]

No incorporation record, certification or facility description is corroborated by any source available to this wiki, and the article makes no statement about any of them.^[2]

The catalogue is broad and the documentation inconsistent across it — an unusual combination, and one that makes generalisation from any single order unsafe.^[5]

The report set associated with this organisation is the largest on the wiki, with several hundred third-party reports across a wide range of analytes.^[5] Reported area percent figures span a wider range than for most entities covered here, with the majority in the high nineties and a visible tail below.

What that tail means is genuinely contested. A large report set will contain more low results than a small one simply by being larger, and a set assembled from purchaser submissions is self-selected in ways that may over- or under-represent poor outcomes: a purchaser who suspects a problem is more likely to test, and a purchaser with a good result is more likely to publish. Neither bias has been quantified, and the article does not claim to know the net direction.^[5][4]

The one statement the set does support is comparative in a limited way: the dispersion of reported figures is wider here than for entities with more standardised certificates. Dispersion is a property of the reports and not necessarily of the material.^[6]

The PeptidePedia tally records 914 self-reported submissions to July 2026 — toward the lower end among the supplier articles. Recurring positive themes are catalogue breadth, price and the availability of testing data; recurring complaints concern documentation inconsistency and variance between orders.^[4] Self-selected; reception rather than quality.^[4]

The reception figure above is a mean of self-reported submissions to PeptidePedia. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.^[4]

Submissions are reproduced as written, with the submitter's own wording. They are self-reported and unverified, and are quoted to show what the tally is made of rather than to support any claim about the organisation.

Pleased to find they hold stock in Germany. Domestic dispatch, day 2, no customs step at all.

Documentation is better than the two suppliers I used before, and the catalogue covers everything I actually order.

Moved here after two bad lots elsewhere. 5 orders in and the Medutest numbers have been flat every single time.

Same lot documentation as the factory ships, but out of their warehouse in the United Kingdom, so it landed on day 3.

Stock said available, stock was available, and it shipped the same day. That sequence is not as common as it should be.

Queried the related-substances total on lot LOT-26-705; they came back with method, column and detection limit. That depth is rare.

Dispatched from their warehouse in Australia rather than from the factory, so the retatrutide 5 mg was with me on day 4.

Lot code on the vial matched the lot code on the certificate exactly. Sounds basic; it is the single best predictor of everything else.

Quoted 5 days, arrived in 5. Tracking updated at every hop from dispatch to door.

Reconstituted the GHRP-2 5 mg and it went clear on contact — no haze, no floaters, no long swirl. Tells you the lyophilisation was done properly.

Vial labels printed rather than handwritten, lot and date legible, cap seal intact on every unit.

Reordered on the strength of the last one and got an identical result. Repeatability is the product.

Janoshik has now seen 4 of their lots through me. Not one has come back outside spec.

The certificate for lot LOT-24-770 carried method, wavelength, water content and an itemised related-substances table. Complete on the first pass.

No customs paperwork, no import wait — it came from their stock in Australia and arrived day 4.

Three compounds on one invoice, all three lot-matched to their own certificates, all three inside spec on independent testing.

Asked a genuinely technical question about pre-dispatch storage and got a reply with numbers in it, inside 5 hours.

Certificate claimed 97.5% on lot LOT-25-104. PeptideMeter came back 97.7%. On an independent column that is as close to agreement as this gets.

The thymosin alpha-1 5 mg arrived on day 3 with the cold pack intact and the seal unbroken. Straightforward, exactly as described.

Costed them per mg against three other suppliers on the same tirzepatide 10 mg spec. Competitive on price and clearly ahead on documentation.

Custom synthesis quote came back with a realistic timeline and they beat it. Purity on delivery matched the signed spec.

Submitted the survodutide 5 mg to VendorInvestigate blind, without telling them the source. 97.9% against a stated 97.9%. The number holds up when nobody knows whose vial it is.

Cold pack was still hard on arrival in Perth on day 4. My logger never went above 7°C across the whole run.

Their warehouse in Canada had the BPC-157 10 mg in stock and it shipped the same afternoon. Tracking never left the country.

Shipped with a stated storage recommendation and a shelf-life figure tied to it, without my asking.

6 orders in eighteen months, no substitutions, no reformulations, everything in stock when the site said it was. Boring is the highest compliment I have.

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.^[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.^[3][6]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.^[3]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.^[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.^[2]

Two frameworks are named in this article only to say what has not been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,^[7] and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.^[8] Neither assessment is available here for this organisation or for any other covered on this wiki.

The article's talk page carries the notability discussion in full, including the standing question of whether entities with no distinguishing features warrant separate articles at all.

• Visit WWB

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain
• Blind sampling

• Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
• Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.